Clinical Trial Update: A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine [Phase 3]

View source ↗

Summary

A Phase 3 double-blind, placebo-controlled trial evaluating intravenous gamma globulin in children with symptomatic HIV infection receiving zidovudine has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Gamma globulin (immunoglobulin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED